US Stock MarketDetailed Quotes

Stoke Therapeutics (STOK)

Watchlist
  • 30.080
  • -1.280-4.08%
Close May 15 16:00 ET
  • 28.500
  • -1.580-5.25%
Post 20:01 ET
1.87BMarket Cap-10.70P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Stoke Therapeutics (STOK) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
-96.07%6.23M
404.50%184.42M
-93.80%1.4M
117.25%10.63M
186.01%13.82M
3,661.12%158.57M
316.34%36.56M
707.07%22.61M
47.94%4.89M
294.72%4.83M
Operating revenue
-96.07%6.23M
404.50%184.42M
-93.80%1.4M
117.25%10.63M
186.01%13.82M
3,661.12%158.57M
316.34%36.56M
707.07%22.61M
47.94%4.89M
294.72%4.83M
Cost of revenue
Gross profit
Operating expense
26.03%59.65M
48.64%205.01M
73.27%62.84M
53.95%53.72M
20.32%41.12M
45.23%47.33M
11.63%137.93M
11.98%36.27M
14.26%34.9M
11.02%34.17M
Selling and administrative expenses
36.31%19.97M
37.49%67.09M
64.64%21.15M
26.28%16.03M
17.07%15.26M
43.38%14.65M
18.08%48.79M
21.06%12.84M
23.57%12.69M
27.44%13.04M
-General and administrative expense
36.31%19.97M
37.49%67.09M
----
----
17.07%15.26M
43.38%14.65M
18.08%48.79M
21.06%12.84M
23.57%12.69M
27.44%13.04M
Research and development costs
21.41%39.67M
54.74%137.92M
78.01%41.7M
69.76%37.7M
22.33%25.86M
46.08%32.68M
8.39%89.13M
7.55%23.42M
9.54%22.21M
2.85%21.14M
Operating profit
-148.02%-53.42M
79.69%-20.59M
-350.00%-61.44M
-43.62%-43.09M
6.96%-27.3M
492.08%111.24M
11.68%-101.37M
53.85%-13.65M
-10.17%-30M
11.79%-29.34M
Net non-operating interest income expense
17.58%3.4M
8.85%13.76M
21.72%3.62M
-2.31%3.46M
2.54%3.79M
19.08%2.89M
27.55%12.64M
14.80%2.97M
33.72%3.55M
43.94%3.7M
Total other finance cost
-17.58%-3.4M
-8.85%-13.76M
-21.72%-3.62M
2.31%-3.46M
-2.54%-3.79M
-19.08%-2.89M
-27.55%-12.64M
-14.80%-2.97M
-33.72%-3.55M
-43.94%-3.7M
Other net income (expense)
-35.71%18K
79.35%-51K
-154.73%-110K
-89.29%3K
158.33%28K
106.54%28K
-248.80%-247K
390.24%201K
-31.71%28K
-217.07%-48K
Other non- operating income (expenses)
-35.71%18K
79.35%-51K
-154.73%-110K
-89.29%3K
158.33%28K
106.54%28K
-248.80%-247K
390.24%201K
-31.71%28K
-217.07%-48K
Income before tax
-143.80%-50M
92.26%-6.89M
-452.70%-57.93M
-49.92%-39.63M
8.61%-23.48M
532.84%114.16M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
Income tax
0
-1.28M
0
1.28M
0
0
Net income
-144.30%-50M
92.26%-6.89M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
Net income continuous Operations
-144.30%-50M
92.26%-6.89M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
Minority interest income
Net income attributable to the parent company
-144.30%-50M
92.26%-6.89M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-144.30%-50M
92.26%-6.89M
-452.70%-57.93M
-45.09%-38.35M
8.61%-23.48M
527.99%112.88M
15.01%-88.98M
61.12%-10.48M
-7.69%-26.43M
16.18%-25.7M
Basic earnings per share
-140.51%-0.79
92.73%-0.12
-455.56%-1
-38.30%-0.65
13.04%-0.4
442.11%1.95
30.67%-1.65
70.00%-0.18
14.55%-0.47
33.33%-0.46
Diluted earnings per share
-141.58%-0.79
92.73%-0.12
-455.56%-1
-38.30%-0.65
13.04%-0.4
433.33%1.9
30.67%-1.65
70.00%-0.18
14.55%-0.47
33.33%-0.46
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue -96.07%6.23M404.50%184.42M-93.80%1.4M117.25%10.63M186.01%13.82M3,661.12%158.57M316.34%36.56M707.07%22.61M47.94%4.89M294.72%4.83M
Operating revenue -96.07%6.23M404.50%184.42M-93.80%1.4M117.25%10.63M186.01%13.82M3,661.12%158.57M316.34%36.56M707.07%22.61M47.94%4.89M294.72%4.83M
Cost of revenue
Gross profit
Operating expense 26.03%59.65M48.64%205.01M73.27%62.84M53.95%53.72M20.32%41.12M45.23%47.33M11.63%137.93M11.98%36.27M14.26%34.9M11.02%34.17M
Selling and administrative expenses 36.31%19.97M37.49%67.09M64.64%21.15M26.28%16.03M17.07%15.26M43.38%14.65M18.08%48.79M21.06%12.84M23.57%12.69M27.44%13.04M
-General and administrative expense 36.31%19.97M37.49%67.09M--------17.07%15.26M43.38%14.65M18.08%48.79M21.06%12.84M23.57%12.69M27.44%13.04M
Research and development costs 21.41%39.67M54.74%137.92M78.01%41.7M69.76%37.7M22.33%25.86M46.08%32.68M8.39%89.13M7.55%23.42M9.54%22.21M2.85%21.14M
Operating profit -148.02%-53.42M79.69%-20.59M-350.00%-61.44M-43.62%-43.09M6.96%-27.3M492.08%111.24M11.68%-101.37M53.85%-13.65M-10.17%-30M11.79%-29.34M
Net non-operating interest income expense 17.58%3.4M8.85%13.76M21.72%3.62M-2.31%3.46M2.54%3.79M19.08%2.89M27.55%12.64M14.80%2.97M33.72%3.55M43.94%3.7M
Total other finance cost -17.58%-3.4M-8.85%-13.76M-21.72%-3.62M2.31%-3.46M-2.54%-3.79M-19.08%-2.89M-27.55%-12.64M-14.80%-2.97M-33.72%-3.55M-43.94%-3.7M
Other net income (expense) -35.71%18K79.35%-51K-154.73%-110K-89.29%3K158.33%28K106.54%28K-248.80%-247K390.24%201K-31.71%28K-217.07%-48K
Other non- operating income (expenses) -35.71%18K79.35%-51K-154.73%-110K-89.29%3K158.33%28K106.54%28K-248.80%-247K390.24%201K-31.71%28K-217.07%-48K
Income before tax -143.80%-50M92.26%-6.89M-452.70%-57.93M-49.92%-39.63M8.61%-23.48M532.84%114.16M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M
Income tax 0-1.28M01.28M00
Net income -144.30%-50M92.26%-6.89M-452.70%-57.93M-45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M
Net income continuous Operations -144.30%-50M92.26%-6.89M-452.70%-57.93M-45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M
Minority interest income
Net income attributable to the parent company -144.30%-50M92.26%-6.89M-452.70%-57.93M-45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -144.30%-50M92.26%-6.89M-452.70%-57.93M-45.09%-38.35M8.61%-23.48M527.99%112.88M15.01%-88.98M61.12%-10.48M-7.69%-26.43M16.18%-25.7M
Basic earnings per share -140.51%-0.7992.73%-0.12-455.56%-1-38.30%-0.6513.04%-0.4442.11%1.9530.67%-1.6570.00%-0.1814.55%-0.4733.33%-0.46
Diluted earnings per share -141.58%-0.7992.73%-0.12-455.56%-1-38.30%-0.6513.04%-0.4433.33%1.930.67%-1.6570.00%-0.1814.55%-0.4733.33%-0.46
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -